Dual imaging agent for magnetic particle imaging and computed tomography

Sitong Liu; Anahita Heshmat; Jennifer Andrew; Izabella Barreto; Carlos M Rinaldi-Ramos

doi:10.1039/d3na00105a

Dual imaging agent for magnetic particle imaging and computed tomography

Nanoscale Adv. 2023 May 1;5(11):3018-3032. doi: 10.1039/d3na00105a. eCollection 2023 May 30.

Authors

Sitong Liu¹, Anahita Heshmat², Jennifer Andrew³, Izabella Barreto², Carlos M Rinaldi-Ramos^{1

4}

Affiliations

¹ Department of Chemical Engineering, University of Florida Gainesville FL 32611 USA carlos.rinaldi@ufl.edu.
² Department of Radiology, University of Florida Gainesville FL 32610-0374 USA.
³ Department of Material Science and Engineering, University of Florida Gainesville FL 32603 USA.
⁴ J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida Gainesville FL 32611-6131 USA.

Abstract

Magnetic particle imaging (MPI) is a novel biomedical imaging modality that allows non-invasive, tomographic, and quantitative tracking of the distribution of superparamagnetic iron oxide nanoparticle (SPION) tracers. While MPI possesses high sensitivity, detecting nanograms of iron, it does not provide anatomical information. Computed tomography (CT) is a widely used biomedical imaging modality that yields anatomical information at high resolution. A multimodal imaging agent combining the benefits of MPI and CT imaging would be of interest. Here we combine MPI-tailored SPIONs with CT-contrast hafnium oxide (hafnia) nanoparticles using flash nanoprecipitation to obtain dual-imaging MPI/CT agents. Co-encapsulation of iron oxide and hafnia in the composite nanoparticles was confirmed via transmission electron microscopy and elemental mapping. Equilibrium and dynamic magnetic characterization show a reduction in effective magnetic diameter and changes in dynamic magnetic susceptibility spectra at high oscillating field frequencies, suggesting magnetic interactions within the composite dual imaging tracers. The MPI performance of the dual imaging agent was evaluated and compared to the commercial tracer ferucarbotran. The dual-imaging agent has MPI sensitivity that is ∼3× better than this commercial tracer. However, worsening of MPI resolution was observed in the composite tracer when compared to individually coated SPIONs. This worsening resolution could result from magnetic dipolar interactions within the composite dual imaging tracer. The CT performance of the dual imaging agent was evaluated in a pre-clinical animal scanner and a clinical scanner, revealing better contrast compared to a commercial iodine-based contrast agent. We demonstrate that the dual imaging agent can be differentiated from the commercial iodine contrast agent using dual energy CT (DECT) imaging. Furthermore, the dual imaging agent displayed energy-dependent CT contrast arising from the combination of SPION and hafnia, making it potentially suitable for virtual monochromatic imaging of the contrast agent distribution using DECT.